DCOY
DCOY
NASDAQ · Biotechnology

Decoy Therapeutics Inc

$2.31
-0.78 (-25.24%)
As of Sep 28, 10:46 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,827.7% upside
Low Target $37.12
Average Target $44.53
High Target $63.68
Current Price $2.31
Current
$2.31
Target
$44.53
$37.12 $44.53 avg $63.68
Scenario Analysis
Bear Case
$37.12
1,506.9%
Low target
Base Case
$44.53
+1,827.7%
Avg target
Bull Case
$63.68
+2,656.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$55.92
-95.9% from high
52-Week Low
$2.18
+6.0% from low
Target vs 52W High
$44.53
-20.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%